4.3 Dressing Categories, Formulary, and Resource Fit
Key Takeaways
- The WCC Treatment domain includes dressing and resource recommendations, which makes formulary and availability relevant to exam scenarios.
- Hydrogels, foams, alginates, hydrofibers, films, contact layers, hydrocolloids, collagen products, and antimicrobial dressings are best understood by function.
- Product selection must consider exudate level, wound depth, infection concern, periwound integrity, patient tolerance, and care setting.
- Exam traps include using a contraindicated or unavailable product because it sounds advanced.
Categories Matter Because Function Matters
The WCC Treatment blueprint includes dressing and resource recommendations plus product categories and functions. Resource is not a throwaway word. A dressing plan must work in the clinic, hospital, home health, long-term care, or outpatient setting where the patient actually receives care.
Categories are easier to learn when tied to function. Hydrogels donate moisture. Foams absorb and cushion. Alginates and hydrofibers manage moderate to heavy drainage and may fill space depending on product form. Transparent films protect low-drainage areas. Contact layers reduce trauma. Hydrocolloids support moist healing in selected low to moderate exudate wounds. Antimicrobial products need an indication.
| Category | Typical Function | Common Exam Caution |
|---|---|---|
| Hydrogel | Donates moisture | Not ideal for heavy exudate |
| Foam | Absorbs and cushions | May be inadequate for very deep dead space alone |
| Alginate or hydrofiber | Handles drainage and fill | Avoid dry wounds without enough moisture |
| Film | Protects and covers | Not for heavy drainage or infected wounds alone |
| Antimicrobial dressing | Addresses bioburden when indicated | Do not use forever without reassessment |
Applied WCC scenario guidance: a home-health patient has a moderately draining shallow wound, fragile skin, limited caregiver help, and a payer limit on supply quantity. The best answer is not automatically the most complex product. It is the dressing plan that fits exudate, protects skin, can be changed safely, is obtainable, and follows provider orders.
Formulary questions test judgment. If two products perform the same function, the available product that meets policy and cost constraints may be the better recommendation. If the formulary product does not meet the wound need, the WCC role is to communicate the rationale for an alternate, not improvise outside the care process.
Antimicrobial dressings are common distractors. Silver, iodine-based, honey, polyhexamethylene biguanide, and other antimicrobial options may be appropriate when bioburden is a concern and policy supports use. They are not automatically required for every chronic wound. Reassessment should determine whether the indication remains.
Exam trap: do not use occlusive or moisture-retentive products blindly over a wound with untreated infection concern, heavy exudate, or fragile periwound risk. The stem may include odor, heat, spreading erythema, pain, or purulence to point toward reassessment and escalation rather than simple product substitution.
Another trap is forgetting removal. A product that controls drainage but causes skin stripping or bleeding at each change may not be the best fit. Securement, adhesive sensitivity, anatomical location, and dressing-change pain are part of product selection.
For test day, match category to indication. Ask whether the product donates moisture, absorbs, fills, protects, reduces trauma, controls odor, or manages bioburden. Then ask whether the patient, setting, formulary, and policy allow it to be used consistently. That two-step approach handles most dressing-category questions.
Which pairing best matches a common dressing category with its main function?
Why does formulary matter in a WCC treatment scenario?
What is the best reason to stop and reassess an antimicrobial dressing plan?